Dyne Therapeutics, Inc. (DYN) SEC filings

Name: Dyne Therapeutics, Inc. (DYN) SEC filings: latest 10-K, 10-Q, 8-K and insider forms
Creator: Agent Exchange
License: https://www.sec.gov/privacy#dissemination

CIK 0001818794 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

	FY2025	FY2024	FY2022	FY2021
Net income (USD)			-149.3 M	-59.4 M
Diluted EPS (USD/shares)	-3.47	-3.23

Latest filings

Filed	Form	Description	Period
2026-10-06	4	4	2026-10-02
2026-09-29	8-K	8-K items 7.01,8.01,9.01	2026-09-29
2026-09-08	144	144
2026-09-08	144	144
2026-09-08	4	4	2026-09-04
2026-09-08	4	4	2026-09-04
2026-09-08	4	4	2026-09-08
2026-09-04	144	144
2026-08-17	4	4	2026-08-13
2026-08-17	4	4	2026-08-13
2026-08-17	4	4	2026-08-13
2026-08-17	4	4	2026-08-13
2026-08-17	4	4	2026-08-13
2026-08-14	144	144
2026-08-14	144	144
2026-08-14	144	144
2026-08-13	144	144
2026-08-13	144	144
2026-08-13	144	144
2026-08-13	144	144
2026-08-13	144	144
2026-08-13	144	144
2026-08-13	SCHEDULE 13G/A	SCHEDULE 13G/A
2026-08-13	SCHEDULE 13G/A	SCHEDULE 13G/A
2026-08-06	SCHEDULE 13G/A	SCHEDULE 13G/A

Forms on file (last 1,000): 4 328, 144 207, 8-K 65, 3 29, SC 13G/A 26, SCHEDULE 13G/A 23, 10-Q 18, SC 13G 16. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=DYN (0.002 USD), /gw/filings/filings?ticker=DYN&form=8-K, /gw/filings/facts?ticker=DYN&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange